We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$19.6B
1-Year Est. Return
32.64%
This Fund
S&P 500
This Quarter
Est. Return
+9.69%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$13.7B
AUM Growth
-$178M
(-1.3%)
Cap. Flow
-$1.14B
Cap. Flow
% of AUM
-8.27%
Top 10 Holdings %
Top 10 Hldgs %
25.57%
Holding
3,040
New
254
Increased
776
Reduced
1,044
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$14.9M |
| 2 |
Palo Alto Networks
PANW
|
+$14.8M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$9.08M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$7.73M |
| 5 |
Crown Holdings
CCK
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$901M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$71.6M |
| 3 |
Apple
AAPL
|
+$11.2M |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$10.7M |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$8.77M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.14% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
YMAB
2501
DELISTED
Y-mAbs Therapeutics
YMAB
| $136K | ﹤0.01% |
20,086
| – | – |
|
2502
Clarus
CLAR
$145M
| $136K | ﹤0.01% |
14,919
| – | – |
|
|
SMMF
2503
DELISTED
Summit Financial Group, Inc.
SMMF
| $136K | ﹤0.01% |
6,592
+39
| +0.6% | +$767 |
|
2504
Arbutus Biopharma
ABUS
$906M
| $136K | ﹤0.01% |
58,981
| – | – |
|
2505
Nerdy
NRDY
$92.6M
| $135K | ﹤0.01% |
32,464
| – | – |
|
2506
Blue Owl Capital
OWL
$19.7B
| $135K | ﹤0.01% |
11,619
-13,945
| -55% | -$150K |
|
2507
Evolution Petroleum
EPM
$135M
| $135K | ﹤0.01% |
+16,752
| New | +$124K |
|
2508
Olema Pharmaceuticals
OLMA
$920M
| $135K | ﹤0.01% |
+14,905
| New | +$90K |
|
2509
Sensata Technologies
ST
$6.61B
| $134K | ﹤0.01% |
2,987
-144
| -5% | -$6.32K |
|
|
PSTL
2510
Postal Realty Trust
PSTL
$701M
| $134K | ﹤0.01% |
9,117
| – | – |
|
2511
Seer Inc
SEER
$116M
| $134K | ﹤0.01% |
31,352
| – | – |
|
2512
El Pollo Loco
LOCO
$471M
| $134K | ﹤0.01% |
15,223
+4,759
| +45% | +$44.6K |
|
2513
Carlyle Group
CG
$18.3B
| $133K | ﹤0.01% |
4,178
-110
| -3% | -$3.21K |
|
2514
John Marshall Bancorp
JMSB
$328M
| $133K | ﹤0.01% |
6,643
| – | – |
|
2515
Forum Energy Technologies
FET
$927M
| $133K | ﹤0.01% |
+5,210
| New | +$123K |
|
2516
HBT Financial
HBT
$1.35B
| $133K | ﹤0.01% |
7,206
+1,811
| +34% | +$33.2K |
|
2517
Daktronics
DAKT
$988M
| $133K | ﹤0.01% |
+20,725
| New | +$122K |
|
2518
Bright Horizons
BFAM
$3.85B
| $132K | ﹤0.01% |
1,433
-404
| -22% | -$34.2K |
|
|
GBIO
2519
DELISTED
Generation Bio
GBIO
| $132K | ﹤0.01% |
2,403
+818
| +52% | +$37.5K |
|
2520
Sutro Biopharma
STRO
$353M
| $132K | ﹤0.01% |
2,838
| – | – |
|
2521
Caribou Biosciences
CRBU
$160M
| $132K | ﹤0.01% |
31,003
| – | – |
|
2522
Zumiez
ZUMZ
$319M
| $132K | ﹤0.01% |
7,900
| – | – |
|
2523
Radiant Logistics
RLGT
$406M
| $131K | ﹤0.01% |
19,561
| – | – |
|
|
KYNB
2524
Kyntra Bio
KYNB
$28.5M
| $131K | ﹤0.01% |
1,946
+54
| +3% | +$22.3K |
|
2525
Robinhood
HOOD
$89.3B
| $131K | ﹤0.01% |
13,148
+1,315
| +11% | +$12.3K |
|
Similar funds
PCM
HHII
EIM
P
BPA
NAM
MIC
MetLife Investment Management's Q2 2023 Portfolio in Review
As of Q2 2023, MetLife Investment Management held 3,040 positions worth $13.7B, down 1.3% from $13.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
MetLife Investment Management withdrew a net $1.14B in Q2 2023, closing 100 positions and reducing 1,044 holdings. Its most notable exit was Evoqua Water Technologies Corp. Common Stock, an estimated $3.05M position sold in full.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
Against the trend, MetLife Investment Management opened a new position in Knife River worth $2.46M.
- MetLife Investment Management's largest Q2 2023 buy was Knife River: 56,478 shares worth $2.46M.
- MetLife Investment Management added most to Meta Platforms (Facebook) in Q2 2023, an estimated $14.9M increase.
- MetLife Investment Management's biggest Q2 2023 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $901M.
- MetLife Investment Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $3.05M.
- MetLife Investment Management's ten largest holdings make up 26% of its $13.7B portfolio in Q2 2023.
- MetLife Investment Management opened 254 new positions and closed 100 in Q2 2023.
- MetLife Investment Management's portfolio value fell 1.3% quarter-over-quarter to $13.7B.
Based on MetLife Investment Management's 13F filing for Q2 2023, filed 10 Aug 2023.